ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1510

Disease Activity In Male Smokers Has A >10-Fold Amplified Effect On Radiographic Damage In Comparison With Female NON-Smokers In Ankylosing Spondylitis

Sofia Ramiro1,2, A.M. van Tubergen3, Robert Landewé4, Carmen Stolwijk5, Maxime Dougados6, Filip Van den Bosch7 and Désirée van der Heijde8, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Rheumatology, Hospital Garcia de Orta, Almada, Portugal, 3Department of Internal Medicine, Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, Netherlands, 5Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 6Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 7Ghent University Hospital, Ghent, Belgium, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Disease Activity, outcome measures and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: II

Session Type: Abstract Submissions (ACR)

Background/Purpose: We have shown that disease activity has an effect on radiographic progression over the long-term and that gender and symptom duration are effect modifiers. Smoking has been shown to predict radiographic progression. We sought to investigate whether smoking influenced this longitudinal relationship between disease activity and radiographic damage.

Methods: Patients from the Outcome in AS International Study (OASIS) were followed-up for 12 years, with biannual clinical and radiographic assessments. Two readers independently scored the x-rays according to the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) and scores were averaged. Disease activity was assessed by the ASDAS-CRP. The relationship between ASDAS and radiographic damage was investigated using generalized estimating equations, with auto-regressive (i.e. adjusted for the 2-year previous mSASSS) models with a 2-year time-lag. Interactions were tested with baseline smoking status and if significant, analyses were repeated in strata.

Results: A total of 127 patients were included (71% males, mean (SD) age 41(12) years, mean symptom duration 18(11) years and 82% HLA-B27 positive). Smoking status modified the relationship between disease activity and radiographic damage significantly (p<0.001), and this effect extended to other strata: males (p=0.002) and patients with shorter symptom duration (<18y) (p=0.009); Overall, an increase in one ASDAS-unit led to an increase in 0.72 mSASSS-units per 2 years. In smokers, this value reached 1.94 mSASSS-units and in male smokers 2.15 mSASSS-units (Table). Comparing the magnitude of the effect of ASDAS on mSASSS in smokers vs non-smokers, smokers had a 5.5 fold amplified effect, whereas male smokers had a 13.4 fold amplified effect compared to female non-smokers. Smokers with short symptom duration had a 8.1-fold amplified effect compared to non-smokers with long symptom duration (Figure).

 Conclusion: Smoking amplifies the effect of disease activity on radiographic damage (5-fold). This effect is further amplified in male smokers (13.4-fold) in comparison with female non-smokers.


Table – Longitudinal relationship between ASDAS and radiographic damage in different strata

Stratification for

Effect analyzed

Multivariable regression models (auto-regressive and time-lagged)

µ  (95%CI)*

Smoking status

   – ASDAS in non-smokers (n = 78)

0.35 (0.04; 0.65)

   – ASDAS in smokers (n = 49)

1.94 (1.00; 2.87)

Smoking status & gender

   – ASDAS in women, non-smokers (n = 29)

0.16 (-0.13; 0.44)

   – ASDAS in women, smokers (n = 9)

0.47 (-0.12; 1.06)

   – ASDAS in men, non-smokers (n = 49)

0.44 (0.02; 0.86)

   – ASDAS in men, smokers (n = 40)

2.15 (1.01; 3.30)

Smoking status & symptom duration

   – ASDAS in symptom duration <18y, non-smokers (n = 39)

0.52 (0.24; 0.80)

   – ASDAS in symptom duration <18y, smokers (n = 31)

2.11 (0.86; 3.36)

   – ASDAS in symptom duration >=18y, non-smokers (n = 35)

0.26 (-0.18; 0.70)

   – ASDAS in symptom duration >=18y, smokers (n = 13)

0.88 (0.15; 1.62)

* Results refer to different multivariable models. De µ indicates the progression in mSASSS per unit increase in ASDAS


Disclosure:

S. Ramiro,
None;

A. M. van Tubergen,
None;

R. Landewé,
None;

C. Stolwijk,
None;

M. Dougados,
None;

F. Van den Bosch,
None;

D. van der Heijde,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-activity-in-male-smokers-has-a-10-fold-amplified-effect-on-radiographic-damage-in-comparison-with-female-non-smokers-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology